CME · PEAD ↑ 100

CME Group reported Q2 2026 EPS of $2.99 on 2026-07-22, beating the $2.91 consensus by $0.08 (+2.7%).

Print-day reaction was +5.0% versus the prior close, a decisive gap-and-hold as the market absorbed the beat. The overnight gap to the T+1 open added a further +0.4%, signalling no meaningful fade in after-hours or pre-market trading. Over the subsequent two trading days the stock drifted an additional +0.4%, a modest but uninterrupted continuation with no give-back. Cumulative abnormal return of +8.8% versus SPY.US — which itself declined 1.2% over the same window — firmly places this in PEAD long territory; the documented drift pattern holds through 2026-10-19.